An indandione that has been used as an anticoagulant. Phenindione has actions similar to warfarin, but it is now rarely employed because of its higher incidence of severe adverse effects.... (From Martindale, The Extra Pharmacopoeia, 30th ed, p234).
- Mechanism
- Curator reviewed
Phenindione inhibits vitamin K reductase, resulting in depletion of the reduced form of vitamin K (vitamin KH2). As vitamin K is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins, this limits the gamma-carboxylation and subsequent activation of the vitamin K-dependent coagulant proteins. The synthesis of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Depression of three of the four vitamin K-dependent coagulation factors (factors II, VII, and X) results in decreased prothrombin levels and a decrease in the amount of thrombin generated and bound to fibrin. This reduces the thrombogenicity of clots.
- Primary indication
- For the treatment of pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, mural thrombosis, and thrombophili.Curator reviewed
- Formula / weight
- C15H10O2 · 222.2387 g/mol (avg)
Resolves to
NFBAXHOPROOJAW-UHFFFAOYSA-NSMILESO=C1C(C(=O)C2=CC=CC=C12)C1=CC=CC=C1What you can answer from here — as of September 12, 2026
Which drugs share a target with Phenindione, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account